Recent trends in the treatment of advanced lung cancerSAIJO, Nagahiro.Cancer science. 2006, Vol 97, Num 6, pp 448-452, issn 1347-9032, 5 p.Article

Translational study in cancer researchSAIJO, Nagahiro.Internal medicine (Tokyo. 1992). 2002, Vol 41, Num 10, pp 770-773, issn 0918-2918, 4 p.Article

What are the reasons for negative phase III trials of molecular-target-based drugs?SAIJO, Nagahiro.Cancer science. 2004, Vol 95, Num 10, pp 772-776, issn 1347-9032, 5 p.Article

Current Perspectives in the Treatment of Small Cell Lung CancerGRECO, F. Anthony; SAIJO, Nagahiro.Seminars in oncology. 2001, Vol 28, Num 2, issn 0093-7754, 54 p., SUP4Conference Proceedings

New drugs for chemotherapy-naive patients with extensive-disease small cell lung cancerETTINGER, David S.Seminars in oncology. 2001, Vol 28, Num 2, pp 27-29, issn 0093-7754, SUP4Conference Paper

Combined-modality therapy for limited-stage small cell lung cancerCURRAN, Walter J.Seminars in oncology. 2001, Vol 28, Num 2, pp 14-22, issn 0093-7754, SUP4Conference Paper

Alternatives to chemotherapy and radiotherapy in the treatment of small cell lung cancerSHEPHERD, Frances A.Seminars in oncology. 2001, Vol 28, Num 2, pp 30-37, issn 0093-7754, SUP4Conference Paper

The importance of drug diversity in the treatment of small cell lung cancerMURRAY, Nevin.Seminars in oncology. 2001, Vol 28, Num 2, pp 38-42, issn 0093-7754, SUP4Conference Paper

Enhanced anti-tumor effect of Trastuzumab in combination with cisplatinNARUSE, Ichiro; FUKUMOTO, Hisao; SAIJO, Nagahiro et al.Japanese journal of cancer research. 2002, Vol 93, Num 5, pp 574-581, issn 0910-5050, 8 p.Article

Disparities in gastric cancer chemotherapy between the east and westOHTSU, Atsushi; YOSHIDA, Shigeaki; SAIJO, Nagahiro et al.Journal of clinical oncology. 2006, Vol 24, Num 14, pp 2188-2196, issn 0732-183X, 9 p.Article

Concurrent versus sequential radiotherapy for small cell lung cancerTSUKADA, Hiroko; YOKOYAMA, Akira; GOTO, Koichi et al.Seminars in oncology. 2001, Vol 28, Num 2, pp 23-26, issn 0093-7754, SUP4Conference Paper

Establishment of a human non-small cell lung cancer cell line resistant to gefitinibKOIZUMI, Fumiaki; SHIMOYAMA, Tatsu; TAGUCHI, Fumiko et al.International journal of cancer. 2005, Vol 116, Num 1, pp 36-44, issn 0020-7136, 9 p.Article

Performing Phase I Clinical Trials of Anticancer Agents: Perspectives from within the European Union and Japan : CCRFORSTER, Martin D; SAIJO, Nagahiro; SEYMOUR, Lesley et al.Clinical cancer research (Print). 2010, Vol 16, Num 6, pp 1737-1744, issn 1078-0432, 8 p.Article

Disparities in cancer care deliveryOLOPADE, Olufunmilayo I; SCHWARTSMANN, Gilberto; SAIJO, Nagahiro et al.Journal of clinical oncology. 2006, Vol 24, Num 14, issn 0732-183X, 84 p.Serial Issue

Pertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathwaySAKAI, Kazuko; YOKOTE, Hideyuki; MURAKAMI-MUROFUSHI, Kimiko et al.Cancer science. 2007, Vol 98, Num 9, pp 1498-1503, issn 1347-9032, 6 p.Article

Geographic variation in the second-line treatment of non-small cell lung cancerEDELMAN, Martin J; SEKINE, Ikuo; TAMURA, Tomohide et al.Seminars in oncology. 2006, Vol 33, Num 1, issn 0093-7754, S39-S44, SUP1Article

Gene expression profiling of exposure to TZT-1027, a novel microtubule-interfering agent, in non-small cell lung cancer PC-14 cells and astrocytesNATSUME, Tsugitaka; NAKAMURA, Takashi; KOH, Yasuhiro et al.Investigational new drugs. 2001, Vol 19, Num 4, pp 293-302, issn 0167-6997Article

Oncoprotein 18 overexpression increases the sensitivity to vindesine in the human lung carcinoma cellsNISHIO, Kazuto; NAKAMURA, Takashi; KOH, Yasuhiro et al.Cancer. 2001, Vol 91, Num 8, pp 1494-1499, issn 0008-543XArticle

Phase I trial of weekly docetaxel in elderly patients with non-small cell lung cancerINOUE, Akira; KUNITOH, Hideo; MORI, Kiyoshi et al.Lung cancer. 2002, Vol 38, Num 2, pp 205-209, issn 0169-5002, 5 p.Article

Upregulated expression of angiogenesis genes and down regulation of cell cycle genes in human colorectal cancer tissue determined by cDNA macroarrayTSUNODA, Takuya; NAKAMURA, Takashi; ISHIMOTO, Kiwao et al.Anticancer research. 2001, Vol 21, Num 1A, pp 137-143, issn 0250-7005Article

A computational model for quantitative analysis of cell cycle arrest and its contribution to overall growth inhibition by anticancer agentsKUH, Hyo-Jeong; NAKAGAWA, Shin-Ichi; USUDA, Jitsuo et al.Japanese journal of cancer research. 2000, Vol 91, Num 12, pp 1303-1313, issn 0910-5050Article

Anticancer effects of ZD6474, a VEGF receptor tyrosine kinase inhibitor, in gefitinib (Iressa)-sensitive and resistant xenograft modelsTAGUCHI, Fumiko; KOH, Yasuhiro; KOIZUMI, Fumiaki et al.Cancer science. 2004, Vol 95, Num 12, pp 984-989, issn 1347-9032, 6 p.Article

Radiation pneumonitis in lung cancer patients : A retrospective study of risk factors and the long-term prognosisINOUE, Akira; KUNITOH, Hideo; SEKINE, Ikuo et al.International journal of radiation oncology, biology, physics. 2001, Vol 49, Num 3, pp 649-655, issn 0360-3016Article

Treatment of relapsed small cell lung cancerPOSTMUS, Pieter E; SMIT, Egbert F.Seminars in oncology. 2001, Vol 28, Num 2, pp 48-52, issn 0093-7754, SUP4Conference Paper

Common arm analysis : One approach to develop the basis for global standardization in clinical trials of non-small cell lung cancerSEKINE, Ikuo; NOKIHARA, Hiroshi; YAMAMOTO, Noboru et al.Lung cancer. 2006, Vol 53, Num 2, pp 157-164, issn 0169-5002, 8 p.Article